Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

MAGOHB Inhibitors

The development of inhibitors that target a protein like MAGOHB would begin with detailed structural and functional analyses. The aim would be to isolate the domains of MAGOHB that are critical for its role in the EJC and identify potential allosteric sites that could be amenable to small molecule binding. These sites might be involved in the protein-protein interactions necessary for EJC assembly or function, or in the direct binding of RNA. Understanding these interactions at a molecular level would be essential for the rational design of inhibitors that could modulate the protein's function. Computational methods, including molecular docking and dynamic simulations, would likely be employed to screen libraries of compounds and predict their binding affinity and specificity for MAGOHB.

Upon identifying potential binding sites, synthetic chemists would then embark on the synthesis of candidate molecules, which would be assessed for their MAGOHB binding abilities through various in vitro assays. Techniques such as fluorescence anisotropy, isothermal titration calorimetry, or nuclear magnetic resonance spectroscopy might be used to measure the interactions between MAGOHB and the inhibitors. These studies could help in determining the binding kinetics and thermodynamics, which are crucial for understanding how these inhibitors interact with the protein. Through iterative rounds of synthesis and testing, the chemical properties of these inhibitors could be refined to enhance their binding characteristics. This approach would not only enhance the basic understanding of MAGOHB's role in RNA processing but also provide insights into the molecular mechanisms that govern the function of the EJC. The exploration of MAGOHB inhibitors would contribute to the broader field of RNA biology by elucidating how small molecules can influence RNA-protein interactions within the cell.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D intercalates into DNA, inhibiting RNA polymerase and potentially decreasing MAGOHB mRNA synthesis.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

α-Amanitin is a potent inhibitor of RNA polymerase II, which could lead to a reduction in mRNA transcription, including that of MAGOHB.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Triptolide is known to inhibit the transcription of RNA, which could decrease the expression of various genes, potentially including MAGOHB.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$42.00
$185.00
$310.00
$650.00
6
(1)

DRB is an adenosine analog that inhibits RNA polymerase II transcription, potentially reducing MAGOHB expression.

Flavopiridol Hydrochloride

131740-09-5sc-207687
10 mg
$311.00
(2)

Flavopiridol inhibits cyclin-dependent kinases involved in cell cycle regulation and RNA transcription, which may affect MAGOHB expression.

Cordycepin

73-03-0sc-203902
10 mg
$99.00
5
(1)

Cordycepin (3'-deoxyadenosine) interferes with RNA synthesis and could lead to reduced expression of certain genes.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$270.00
$465.00
$1607.00
$2448.00
$5239.00
4
(1)

Rocaglamide inhibits translation initiation and could suppress the production of proteins, such as MAGOHB, at the translational level.

Homoharringtonine

26833-87-4sc-202652
sc-202652A
sc-202652B
1 mg
5 mg
10 mg
$51.00
$123.00
$178.00
11
(1)

Homoharringtonine inhibits protein synthesis by preventing the initial elongation step of translation, potentially affecting MAGOHB.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Anisomycin is a potent inhibitor of peptide bond formation and protein synthesis in eukaryotic cells, possibly reducing MAGOHB levels.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide inhibits eukaryotic protein synthesis by interfering with the translocation step in the ribosome, affecting overall protein levels.